Cases & Deals

Sanofi challenges Amgen's patent applications for anti-PCSK9 antibodies before Australian Patent Office

Clients Regeneron Pharmaceuticals, Inc.; Sanofi

Jones Day is acting in an opposition proceeding for Sanofi and Regeneron in relation to their challenge to a portfolio of applications held by Amgen Inc. that claim anti-PCSK9 antibodies and their use in the treatment of hypercholesterolemia.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.